论文信息 - KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. - 字舞流文

KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer.

P. Kienle | S. Post | F. Wenz | R. Hofheinz | P. Erben | A. Hochhaus | P. Ströbel | G. Kähler | B. Hanfstein | K. Horisberger | J. Popa | Beatrice Bohn